Hialid®/Hyalein® (sodium hyaluronate) ophthalmic solution in dry eye syndrome: a profile of its use Kate McKeageKatherine A. Lyseng-Williamson Adis Drug Q&A 01 August 2018 Pages: 405 - 410
Amphetamine extended-release oral suspension (Adzenys ER™) and orally disintegrating tablets (Adzenys XR-ODT®) in attention-deficit hyperactivity disorder: a profile of their use Katherine A. Lyseng-Williamson Adis Drug Q&A 01 August 2018 Pages: 411 - 419
Preventing and managing dimethyl fumarate-related adverse effects in patients with multiple sclerosis may improve adherence Adis Medical Writers Drug Reactions and Interactions 03 August 2018 Pages: 420 - 424
Tattooing is possible in many patients with medical or skin conditions as long as disease-specific recommendations are followed Adis Medical Writers Practical Issues and Updates 18 June 2018 Pages: 425 - 428
Phenobarbital monotherapy for alcohol withdrawal syndrome in the non-intensive care unit setting: a review Stephanie V. Phan Review Article 24 May 2018 Pages: 429 - 436
Associations between Drug Burden Index, medication appropriateness and patient-reported outcomes in the community pharmacy setting in Malaysia Syed Shahzad HasanAnnita Shi Chin LiewZaheer-Ud-Din Babar Original Research Article 25 May 2018 Pages: 437 - 443
Management and outcome of Stevens–Johnson syndrome and toxic epidermal necrolysis in patients admitted to Kenyatta National Hospital K. K. IrunguD. G. NyamuS. A. Opanga Original Research Article 07 May 2018 Pages: 444 - 450
